Market Cap 189.72M
Revenue (ttm) 59.35M
Net Income (ttm) -65.28M
EPS (ttm) N/A
PE Ratio 0.00
Forward PE N/A
Profit Margin -109.99%
Debt to Equity Ratio 0.59
Volume 1,073,800
Avg Vol 779,998
Day's Range N/A - N/A
Shares Out 82.85M
Stochastic %K 35%
Beta 2.52
Analysts Strong Sell
Price Target $6.70

Company Profile

Codexis, Inc. provides enzymatic solutions for therapeutics manufacturing, leveraging its proprietary CodeEvolver technology platform to discover, develop, and enhance novel enzymes in the United States, Canada, Latin America, Europe, the Middle East, Africa, Australia, New Zealand, Southeast Asia, and China. The company develops its proprietary ECO Synthesis manufacturing platform to enable the scaled manufacture of RNAi therapeutics through an enzymatic route. It has a license agreement with A...

Industry: Biotechnology
Sector: Healthcare
Phone: 650 421 8100
Address:
200 Penobscot Drive, Redwood City, United States
TheHowlingMadness
TheHowlingMadness Jun. 21 at 12:57 AM
0 · Reply
djohndjohn
djohndjohn Jun. 20 at 4:42 PM
$CDXS What a joke, way to go Dilly!
0 · Reply
MrMBOT
MrMBOT Jun. 19 at 2:28 AM
$CDXS inside buy recently.
1 · Reply
Fingerlickengood
Fingerlickengood Jun. 18 at 4:58 PM
$CDXS Keeping a close eye....one morning investors here may very well wake up to a similar PR. $LLY $VERV https://investor.lilly.com/news-releases/news-release-details/lilly-acquire-verve-therapeutics-advance-one-time-treatments
1 · Reply
rangerhawkeye
rangerhawkeye Jun. 17 at 8:56 PM
$CDXS added this and $TYRA , big insider buys by both
0 · Reply
Massimo1988
Massimo1988 Jun. 17 at 8:05 PM
BIG WINNERS WITH THE BIG BEAUTIFUL BILL ON JULY Here main stocks positively impacted by the Big Beautiful Bill on 4 July that can go on radar by huge firms with liquidity wanted to invest on the BIG BEAUTIFUL BILL’S WINNER $ANDE $CDXS $PSX $CCJ AEMETIS (NASDAQ: AMTX) will get government support The Senate improved on the House version for biofuels that will become law on 4 July under the Big Beautiful Bill Key items: - negative carbon intensity is specifically allowed for biofuels from animal manure (such as dairy and swine). This resolves the issue of how dairy RNG receives a huge amount of cash from 45Z. - ⁠extends 45Z to year 2031 - ⁠fully transferable tax credits until 2031 - ⁠no indirect land use penalty for any biofuels (highly valuable for RD and SAF using soy feedstock, but worth millions each year for every ethanol plant
1 · Reply
Fingerlickengood
Fingerlickengood Jun. 17 at 6:05 PM
$CDXS $NVS https://www.medscape.com/viewarticle/this-drug-statin-alternative-2025a1000g4k
2 · Reply
in7seczone
in7seczone Jun. 16 at 9:43 PM
$CDXS Opaleye Management bought 250,000 share costing $560,008.98. The shares were purchased on 6/12-6/13-6/16. They know what is about to happen. https://fintel.io/n/us/cdxs/opaleye-management
2 · Reply
Bondra
Bondra Jun. 16 at 2:50 PM
$CDXS Looking at the chart with all that we know - im scratching my head. Feels like i should load the boat. Any bears still around to talk me out of it?
1 · Reply
valueforme
valueforme Jun. 14 at 1:39 PM
$CDXS Reading more about Japanese company Nitto, patent company of Nitto Avecia, which os one of CDMOs that Codexis is working with. Nitto is a large holding with multiple business areas, life science manufacturing is just one of them. I like their focus on innovation and sustainability. Codexis fits very well into this model. https://www.nitto.com/us/en/sustainability/report/
0 · Reply
Latest News on CDXS
Codexis, Inc. (CDXS) Q1 2025 Earnings Call Transcript

May 14, 2025, 6:50 PM EDT - 5 weeks ago

Codexis, Inc. (CDXS) Q1 2025 Earnings Call Transcript


Codexis Reports First Quarter 2025 Financial Results

May 14, 2025, 4:05 PM EDT - 5 weeks ago

Codexis Reports First Quarter 2025 Financial Results


Codexis Announces New Employment Inducement Grants

Mar 7, 2025, 4:05 PM EST - 3 months ago

Codexis Announces New Employment Inducement Grants


Codexis, Inc. (CDXS) Q4 2024 Earnings Call Transcript

Feb 27, 2025, 10:20 PM EST - 4 months ago

Codexis, Inc. (CDXS) Q4 2024 Earnings Call Transcript


Codexis Appoints Arthur Levin, PhD, to Strategic Advisory Board

Feb 6, 2025, 4:05 PM EST - 4 months ago

Codexis Appoints Arthur Levin, PhD, to Strategic Advisory Board


Codexis Appoints Christos Richards to Board of Directors

Jan 16, 2025, 4:05 PM EST - 5 months ago

Codexis Appoints Christos Richards to Board of Directors


Codexis to Participate in Upcoming Healthcare Conferences

Nov 4, 2024, 4:05 PM EST - 8 months ago

Codexis to Participate in Upcoming Healthcare Conferences


Codexis, Inc. (CDXS) Q3 2024 Earnings Call Transcript

Oct 31, 2024, 10:48 PM EDT - 8 months ago

Codexis, Inc. (CDXS) Q3 2024 Earnings Call Transcript


Codexis Publishes FY2023 Sustainability Disclosures

Aug 15, 2024, 4:05 PM EDT - 11 months ago

Codexis Publishes FY2023 Sustainability Disclosures


Codexis, Inc. (CDXS) Q2 2024 Earnings Call Transcript

Aug 8, 2024, 11:01 PM EDT - 11 months ago

Codexis, Inc. (CDXS) Q2 2024 Earnings Call Transcript


Codexis, Inc. (CDXS) Q1 2024 Earnings Call Transcript

May 2, 2024, 8:24 PM EDT - 1 year ago

Codexis, Inc. (CDXS) Q1 2024 Earnings Call Transcript


Codexis, Inc. (CDXS) Q4 2023 Earnings Call Transcript

Feb 28, 2024, 10:39 PM EST - 1 year ago

Codexis, Inc. (CDXS) Q4 2023 Earnings Call Transcript


Codexis, Inc. (CDXS) Q3 2023 Earnings Call Transcript

Nov 2, 2023, 9:32 PM EDT - 1 year ago

Codexis, Inc. (CDXS) Q3 2023 Earnings Call Transcript


Codexis Reports Third Quarter 2023 Financial Results

Nov 2, 2023, 4:05 PM EDT - 1 year ago

Codexis Reports Third Quarter 2023 Financial Results


TheHowlingMadness
TheHowlingMadness Jun. 21 at 12:57 AM
0 · Reply
djohndjohn
djohndjohn Jun. 20 at 4:42 PM
$CDXS What a joke, way to go Dilly!
0 · Reply
MrMBOT
MrMBOT Jun. 19 at 2:28 AM
$CDXS inside buy recently.
1 · Reply
Fingerlickengood
Fingerlickengood Jun. 18 at 4:58 PM
$CDXS Keeping a close eye....one morning investors here may very well wake up to a similar PR. $LLY $VERV https://investor.lilly.com/news-releases/news-release-details/lilly-acquire-verve-therapeutics-advance-one-time-treatments
1 · Reply
rangerhawkeye
rangerhawkeye Jun. 17 at 8:56 PM
$CDXS added this and $TYRA , big insider buys by both
0 · Reply
Massimo1988
Massimo1988 Jun. 17 at 8:05 PM
BIG WINNERS WITH THE BIG BEAUTIFUL BILL ON JULY Here main stocks positively impacted by the Big Beautiful Bill on 4 July that can go on radar by huge firms with liquidity wanted to invest on the BIG BEAUTIFUL BILL’S WINNER $ANDE $CDXS $PSX $CCJ AEMETIS (NASDAQ: AMTX) will get government support The Senate improved on the House version for biofuels that will become law on 4 July under the Big Beautiful Bill Key items: - negative carbon intensity is specifically allowed for biofuels from animal manure (such as dairy and swine). This resolves the issue of how dairy RNG receives a huge amount of cash from 45Z. - ⁠extends 45Z to year 2031 - ⁠fully transferable tax credits until 2031 - ⁠no indirect land use penalty for any biofuels (highly valuable for RD and SAF using soy feedstock, but worth millions each year for every ethanol plant
1 · Reply
Fingerlickengood
Fingerlickengood Jun. 17 at 6:05 PM
$CDXS $NVS https://www.medscape.com/viewarticle/this-drug-statin-alternative-2025a1000g4k
2 · Reply
in7seczone
in7seczone Jun. 16 at 9:43 PM
$CDXS Opaleye Management bought 250,000 share costing $560,008.98. The shares were purchased on 6/12-6/13-6/16. They know what is about to happen. https://fintel.io/n/us/cdxs/opaleye-management
2 · Reply
Bondra
Bondra Jun. 16 at 2:50 PM
$CDXS Looking at the chart with all that we know - im scratching my head. Feels like i should load the boat. Any bears still around to talk me out of it?
1 · Reply
valueforme
valueforme Jun. 14 at 1:39 PM
$CDXS Reading more about Japanese company Nitto, patent company of Nitto Avecia, which os one of CDMOs that Codexis is working with. Nitto is a large holding with multiple business areas, life science manufacturing is just one of them. I like their focus on innovation and sustainability. Codexis fits very well into this model. https://www.nitto.com/us/en/sustainability/report/
0 · Reply
valueforme
valueforme Jun. 13 at 1:38 PM
$CDXS Redeploying SGMT earnings. Got back to the full position here
1 · Reply
djohndjohn
djohndjohn Jun. 10 at 4:13 PM
$CDXS Diluted by another 8 million shares NICE!!!
0 · Reply
djohndjohn
djohndjohn Jun. 10 at 3:33 PM
$CDXS ASM in half hour. Will the on going nothingness continue or will we finally here something of substance?
0 · Reply
Fingerlickengood
Fingerlickengood Jun. 10 at 2:33 PM
$CDXS “In addition, three presentations from contract development and manufacturing organizations (CDMOs) including Bachem, Nitto Avecia, and ST Pharm validated the transferability of Codexis’ ligation processes to their in-house facilities.” https://www.biospace.com/press-releases/codexis-landmark-presentations-at-tides-usa-highlight-reproducibility-and-process-simplification-of-the-eco-synthesis-platform-for-manufacturing-sirna
1 · Reply
Fingerlickengood
Fingerlickengood Jun. 10 at 2:31 PM
$CDXS https://www.arcadis.com/en-us/projects/north-america/united-states/nitto-avecia
0 · Reply
xbizo
xbizo Jun. 7 at 3:47 PM
$CDXS Thanks for the updates and theories!
0 · Reply
Fingerlickengood
Fingerlickengood Jun. 6 at 10:14 PM
$CDXS Interesting coincidence!? https://dealstream.com/d/biz-sale/pharma-mfg/5xoygv
3 · Reply
Fingerlickengood
Fingerlickengood Jun. 6 at 10:03 PM
$CDXS If he's at Jefferies saying this, and they are liquidating the ATM, and it appears they have proven they can potentially scale the production of Inclisiran, AND Inclisiran has just been clinically shown to immediately reduce LDL-C by 45-50% with a twice a year dosing of patients, we may have solved the riddle! https://www.tctmd.com/news/inclisiran-effective-monotherapy-lower-risk-primary-prevention
0 · Reply
Fingerlickengood
Fingerlickengood Jun. 6 at 9:34 PM
$CDXS $NVS I'm starting to think the commercial production of Inclisiran is the 'revenue generating contract' being kept under wraps, "having met the pre-specified criteria to support scaling to industrial capacity." This could be VERY SIGNIFICANT if so considering the implications to IMMEDIATELY treat ACS! They wouldn't waste time to build out capacity, hence, 'possibly' the money grab from ATM to do so quickly. BIG investors such as Opaleye Management would be diving in hand over fist if they had any knowledge of this happening behind the scene! https://www.tctmd.com/news/inclisiran-plus-usual-care-improves-ldl-control-acs-victorion-inception
1 · Reply
Fingerlickengood
Fingerlickengood Jun. 6 at 7:57 PM
$CDXS https://www.precedenceresearch.com/lipid-lowering-drugs-market
0 · Reply
Fingerlickengood
Fingerlickengood Jun. 6 at 7:55 PM
$CDXS $BCHMF $NVS $ALNY https://www.pharmacytimes.com/view/nla-2025-inclisiran-with-standard-care-provides-rapid-sustained-lowering-of-ldl-c-in-patients-with-recent-acute-coronary-syndrome
1 · Reply
valueforme
valueforme Jun. 5 at 7:05 PM
$CDXS Listening to Dilly at Jeffries now. The estimated cost of GMP facility is 30M over 2 years. So, if they ATMed for 15M in May, this might mean they are really close to buy the facility ~35k sq ft GMP facility from some in trouble gene & cell therapy player.
1 · Reply